These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
408 related articles for article (PubMed ID: 18376759)
1. How to differentiate liver lesions in cirrhosis. Bartolozzi C; Crocetti L; Della Pina MC JBR-BTR; 2007; 90(6):475-81. PubMed ID: 18376759 [TBL] [Abstract][Full Text] [Related]
3. Guidelines for imaging focal lesions in liver cirrhosis. Lencioni R; Crocetti L; Della Pina MC; Cioni D Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):697-703. PubMed ID: 19072346 [TBL] [Abstract][Full Text] [Related]
4. Dysplastic nodules in cirrhotic liver: arterial phase enhancement at CT and MR imaging--a case report. Krinsky GA; Theise ND; Rofsky NM; Mizrachi H; Tepperman LW; Weinreb JC Radiology; 1998 Nov; 209(2):461-4. PubMed ID: 9807574 [TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Fracanzani AL; Burdick L; Borzio M; Roncalli M; Bonelli N; Borzio F; Maraschi A; Fiorelli G; Fargion S Hepatology; 2001 Dec; 34(6):1109-12. PubMed ID: 11731999 [TBL] [Abstract][Full Text] [Related]
6. Hepatocellular nodules in liver cirrhosis: contrast-enhanced MR. Bartolozzi C; Battaglia V; Bozzi E Abdom Imaging; 2011 Jun; 36(3):290-9. PubMed ID: 21267561 [TBL] [Abstract][Full Text] [Related]
7. The role of contrast enhanced ultrasound (CEUS) in the assessment of liver nodules in patients with cirrhosis. Dănilă M; Sporea I; Sirli R; Popescu A; Sendroiu M; Martie A Med Ultrason; 2010 Jun; 12(2):145-9. PubMed ID: 21173943 [TBL] [Abstract][Full Text] [Related]
8. Pitfalls in the imaging diagnosis of hepatocellular nodules in the cirrhotic and noncirrhotic liver. Yoshimitsu K; Irie H; Aibe H; Tajima T; Nishie A; Asayama Y; Matake K; Nakayamka T; Kakihara D; Honda H Intervirology; 2004; 47(3-5):238-51. PubMed ID: 15383733 [TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced ultrasound for the differentiation of small atypical hepatocellular carcinomas from dysplastic nodules in cirrhosis. Shin SK; Kim YS; Choi SJ; Shim YS; Jung DH; Kwon OS; Choi DJ; Kim JH Dig Liver Dis; 2015 Sep; 47(9):775-82. PubMed ID: 26043653 [TBL] [Abstract][Full Text] [Related]
10. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging. Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278 [TBL] [Abstract][Full Text] [Related]
11. Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm. Forner A; Vilana R; Bianchi L; Rodríguez-Lope C; Reig M; García-Criado MÁ; Rimola J; Solé M; Ayuso C; Bru C; Bruix J J Hepatol; 2015 Jan; 62(1):150-5. PubMed ID: 25173969 [TBL] [Abstract][Full Text] [Related]
12. Diagnosing Borderline Hepatic Nodules in Hepatocarcinogenesis: Imaging Performance. Choi BI; Lee JM; Kim TK; Dioguardi Burgio M; Vilgrain V AJR Am J Roentgenol; 2015 Jul; 205(1):10-21. PubMed ID: 26102378 [TBL] [Abstract][Full Text] [Related]
13. Imaging of hepatocellular carcinoma: practical guide to differential diagnosis. Anis M; Irshad A Clin Liver Dis; 2011 May; 15(2):335-52, vii-x. PubMed ID: 21689617 [TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis. Iavarone M; Manini MA; Sangiovanni A; Fraquelli M; Forzenigo LV; Di Tommaso L; Aghemo A; Roncalli M; Ronchi G; Colombo M Dig Liver Dis; 2013 Jan; 45(1):43-9. PubMed ID: 23022425 [TBL] [Abstract][Full Text] [Related]
15. Characterization of dysplastic nodules, early hepatocellular carcinoma and progressed hepatocellular carcinoma in cirrhosis with contrast-enhanced ultrasound. Giorgio A; Calisti G; di Sarno A; Farella N; de Stefano G; Scognamiglio U; Giorgio V Anticancer Res; 2011 Nov; 31(11):3977-82. PubMed ID: 22110230 [TBL] [Abstract][Full Text] [Related]
16. Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy. Sersté T; Barrau V; Ozenne V; Vullierme MP; Bedossa P; Farges O; Valla DC; Vilgrain V; Paradis V; Degos F Hepatology; 2012 Mar; 55(3):800-6. PubMed ID: 22006503 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive Comparison of Multiple-Detector Computed Tomography and Dynamic Magnetic Resonance Imaging in the Diagnosis of Hepatocellular Carcinoma with Varying Degrees of Fibrosis. Lin MT; Wang CC; Cheng YF; Eng HL; Yen YH; Tsai MC; Tseng PL; Chang KC; Wu CK; Hu TH PLoS One; 2016; 11(11):e0166157. PubMed ID: 27829060 [TBL] [Abstract][Full Text] [Related]
18. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Willatt JM; Hussain HK; Adusumilli S; Marrero JA Radiology; 2008 May; 247(2):311-30. PubMed ID: 18430871 [TBL] [Abstract][Full Text] [Related]
19. Hepatocellular nodules in liver cirrhosis: MR evaluation. Lee JM; Choi BI Abdom Imaging; 2011 Jun; 36(3):282-9. PubMed ID: 21399975 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic sensitivity of hepatocellular carcinoma imaging and its application to non-cirrhotic patients. Lin MT; Chen CL; Wang CC; Cheng YF; Eng HL; Wang JH; Chiu KW; Lee CM; Hu TH J Gastroenterol Hepatol; 2011 Apr; 26(4):745-50. PubMed ID: 21418303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]